Key Takeaways
- Everyone begins on a gentle starter strength (
0.25 mgWegovy or2.5 mgMounjaro) for at least four weeks to let digestive receptors adapt smoothly. - Week 1 responses vary widely: some patients notice quieter cravings or mild nausea within 48 hours, while others feel completely unchanged—both are normal.
- Weeks 2 and 3 bring steadier drug levels, clearer mealtime fullness cues, and fading early digestive symptoms.
- At Week 4, you and your clinician decide together whether to step up or stay at your starter dose based on comfort, appetite balance, and side effects.
Why Month 1 Looks Different for Everyone
Whether you are preparing for your very first semaglutide or tirzepatide injection or halfway through week two wondering if your response is “normal,” knowing the typical four-week arc takes the guesswork out of starting.
Your Week-by-Week Month 1 Roadmap
| Week | Typical Physical & Appetite Experience | Best Focus for the Week |
|---|---|---|
| Week 1: First Dose | Wide range: mild queasiness, slight fatigue, or early fullness for some; zero noticeable change yet for others. Mealtime hunger remains normal. | Hydrate well (2+ L/day), keep meals light and low-grease, and note how days 1–3 feel. |
| Week 2: Building Levels | Because weekly GLP-1s have a ~5–7 day half-life, systemic levels gently build; smaller portions begin feeling more satisfying. | Prioritize 25–30 g protein at meals and eat slowly so fullness signals register in time. |
| Week 3: Finding Rhythm | Early mild GI adjustments usually settle; cravings between meals soften and energy stabilizes. | Layer in consistent brisk walks or 2–3 strength sessions to protect lean muscle. |
| Week 4: Review & Next Step | Steady baseline adaptation established; ideal checkpoint to assess Month 2 dosing with your clinician. | Review side effects, energy, and appetite control—no rush to escalate if still adapting. |
Answers to Common Month 1 Worries
- “What if I haven’t lost weight yet by Week 4?” Completely normal on an introductory starter dose. Starter strengths prioritize safety and tolerability; consistent fat loss often accelerates at Month 2 (
0.5 mgsemaglutide /5 mgtirzepatide) and beyond. - “Is it bad that I still get hungry for lunch and dinner?” Not at all—healthy mealtime hunger means you can nourish your muscles and metabolism properly.
- “When should I message a clinician right away?” Reach out promptly if you experience persistent vomiting preventing hydration, severe constipation unresponsive to fluids/gentle remedies, severe abdominal pain, or noticeable mood changes.
Start and progress at a pace built around your body with Amble’s clinical team.
Medical Editorial Review: Reviewed by the Amble Clinical Editorial Team. This article is for educational purposes only and does not replace an individualized consultation with a licensed healthcare professional.
Related Clinical Guides
GLP-1 & Weight Loss · 6 min readHow Do GLP-1 Side Effects Compare Between Treatments?Comparing nausea, digestive changes, and tolerability across semaglutide, tirzepatide, and liraglutide—plus how clinicians tailor dosing to minimize symptoms.GLP-1 & Weight Loss · 5 min readWhat Does Wegovy Do in the Body? The Science ExplainedDiscover how semaglutide interacts with your brain, stomach, and pancreas to quiet cravings, prolong fullness, and support steady metabolic weight loss.GLP-1 & Weight Loss · 6 min readWhat Is GLP-1, and What Does It Have to Do With Weight?A clear guide to glucagon-like peptide-1—how your gut naturally produces it, how it coordinates hunger and insulin, and why GLP-1 therapies transform weight care.
Your personalizedweight care plan
Clinician-prescribed GLP-1 & metabolic care, 100% online.